4.8 Article

Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

Journal

CANCER CELL
Volume 32, Issue 4, Pages 520-+

Publisher

CELL PRESS
DOI: 10.1016/j.ccell.2017.08.017

Keywords

-

Funding

  1. Cancer Research UK [C13468/A13982, C13468/A23536]
  2. CRIS Cancer Foundation
  3. Abbie's Army
  4. DIPG Collaborative
  5. Cure Starts Now Foundation
  6. McKenna Claire Foundation
  7. Lyla Nsouli Foundation
  8. National Institutes of Health [R01NS085336, R01NS091620]
  9. Dragon Master Foundation
  10. Kortney Rose Foundation
  11. Musella Foundation For Brain Tumor Research Information
  12. Gray Matters Foundation
  13. Pediatric Brain Tumor Foundation
  14. INSTINCT network - Brain Tumour Charity
  15. Great Ormond Street Children's Charity
  16. Children with Cancer UK
  17. NHS
  18. ICR
  19. Sao Paulo Research Foundation [2011/08523-7, 2012/08287-4]
  20. Christopher's Smile
  21. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/08523-7] Funding Source: FAPESP
  22. Cancer Research UK [13982, 23536] Funding Source: researchfish
  23. Children with Cancer UK [14-175] Funding Source: researchfish
  24. Rosetrees Trust [M417, M200-F1] Funding Source: researchfish
  25. The Brain Tumour Charity [16/193] Funding Source: researchfish

Ask authors/readers for more resources

We collated data from 157 unpublished cases of pediatric high-grade glioma and diffuse intrinsic pontine glioma and 20 publicly available datasets in an integrated analysis of > 1,000 cases. We identified co-segregating mutations in histone-mutant subgroups including loss of FBXW7 in H3.3G34R/V, TOP3A rearrangements in H3.3K27M, and BCOR mutations in H3.1K27M. Histone wild-type subgroups are refined by the presence of key oncogenic events or methylation profiles more closely resembling lower-grade tumors. Genomic aberrations increase with age, highlighting the infant population as biologically and clinically distinct. Uncommon pathway dysregulation is seen in small subsets of tumors, further defining the molecular diversity of the disease, opening up avenues for biological study and providing a basis for functionally defined future treatment stratification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available